anti-CD3/anti-BAFF-R bispecific T-cell engager (PeproMene Bio)

N/A

Report date: 2026/03/19 16:57:17

Base Information

Drug Nameanti-CD3/anti-BAFF-R bispecific T-cell engager (PeproMene Bio)
Drug Alias NameBAFFR BiTE
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionT cell surface glycoprotein CD3 modulatorsB-cell activating factor receptor modulators
TargetsT cell surface glycoprotein CD3B-cell activating factor receptor
Therapy Area/IndicationsAutoimmune DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPeproMene Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesPeproMene Bio Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A